Literature DB >> 7864434

Malignant hyperthermia during sevoflurane administration.

A Ducart1, P Adnet, B Renaud, B Riou, R Krivosic-Horber.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7864434     DOI： 10.1097/00000539-199503000-00031

Source DB:  PubMed          Journal:  Anesth Analg        ISSN： 0003-2999            Impact factor:   5.108


× No keyword cloud information.
  5 in total

Review 1.  Sevoflurance: approaching the ideal inhalational anesthetic. a pharmacologic, pharmacoeconomic, and clinical review.

Authors:  L Delgado-Herrera; R D Ostroff; S A Rogers
Journal:  CNS Drug Rev       Date:  2001

Review 2.  Sevoflurane. A review of its pharmacodynamic and pharmacokinetic properties and its clinical use in general anaesthesia.

Authors:  S S Patel; K L Goa
Journal:  Drugs       Date:  1996-04       Impact factor: 9.546

Review 3.  Malignant hyperthermia.

Authors:  R Ben Abraham; P Adnet; V Glauber; A Perel
Journal:  Postgrad Med J       Date:  1998-01       Impact factor: 2.401

4.  Anesthetic management in Charcot-Marie-Tooth disease type 2 due to a mutation in the mitofusin-2 gene.

Authors:  Paolo Vinci; Giovanni Lapi
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2011-04

5.  Anesthetic Management of A Patient with Charcot-Marie-Tooth Disease for 2-stage Revision of Total Knee Replacement.

Authors:  Eleftheria Soulioti; Foteini Kavezou; Georgia Efstathiou; Chrysanthi Batistaki; Agathi Karakosta; Georgia Kostopanagiotou
Journal:  Turk J Anaesthesiol Reanim       Date:  2021-04-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.